Exosome RNA Exosome RNA Research & Industry News
Liquid biopsy is a new, minimally invasive technology for detection of disease biomarkers without the need for costly or invasive procedures. In this video, Dr. Brian Adams talks about the role of miRNA from exosomes as potential circulating biomarkers, challenges and recommended techniques for isolating these tiny microvesicles. Liquid biopsies promise to revolutionize the way serious diseases are detected and monitored.
Don't Miss
- Therapeutic potential of broccoli-derived extracellular vesicles as nanocarriers of exogenous miRNAs
- Urinary exosomal long non-coding RNAs as noninvasive biomarkers for diagnosis of bladder cancer by RNA sequencing
- Extracellular vesicles as central regulators of blood vessel function in cancer
- Rion Aesthetics’ novel exosome technology validated in clinical study
- An integrated microfluidic device for accurate extracellular vesicle quantification and protein markers analysis directly from human whole blood
- Extracorporeal blood filter removes circulating tumor cells
- Combining single-cell RNA sequencing of peripheral blood mononuclear cells and exosomal transcriptome to reveals the cellular and genetic profiles in COPD
- Carnegie Mellon exosome engineering tech licensed to Coya Therapeutics
- Extracellular vesicles elicit protective immune responses against Salmonella infection
- Determine the effect of older versus younger peoples’ exosomes on muscle cell
